Home › Companies › Pathos › Senior Computational Biologist, Oncology
Senior Computational Biologist, Oncology
Pathos · New York City, NY, United States · On Site · Active · $170,000–$210,000 / year · Rippling ATS
Job facts
| Field | Value |
|---|---|
| Company | Pathos |
| Title | Senior Computational Biologist, Oncology |
| Normalized title | - |
| Department / team | Computational Biology |
| Location | New York City, NY, United States |
| Work model | On Site |
| Employment type | Full Time |
| Salary | $170,000–$210,000 / year |
| Status | active |
| ATS provider | Rippling ATS |
| Posted / first seen | 2026-01-09 / 2026-05-29 |
| Changed / last seen | 2026-06-06 / 2026-06-06 |
Related slices
| Page | What it contains | Open |
|---|---|---|
| Company jobs | Active postings from Pathos. | Open |
| Company breakdowns | Role, location, ATS, and work model facets for this company. | Open |
| ATS provider jobs | Active postings observed through Rippling ATS. | Open |
| Provider filtered search | The same provider as a filtered job collection. | Open |
| City jobs | Active postings in New York City. | Open |
| Department jobs | Active postings in Computational Biology. | Open |
| Work model jobs | Active On Site postings. | Open |
| Lifecycle events | Open, update, close, and reopen events for this posting. | Open |
| Original posting | Canonical source or apply URL captured from the ATS. | Open |
Linked records
| Company | Pathos |
| Source | 2d66e9b5-1b63-475c-a03a-943980720722 |
| ATS provider | Rippling ATS |
Description
company
Drug development shouldn’t be guesswork, not when patients are waiting.
Pathos is building a next-generation biotech with AI at the core. Not as a feature, but as the operating system for how medicines get developed. We believe most drugs don’t fail because the science was wrong. They fail because they were tested in the wrong patients, with the wrong assumptions, in trials that couldn’t answer the real question: who benefits, and why?
Pathos exists to change that. We’re building the largest foundation model in oncology and pairing it with proprietary AI systems, deep oncology expertise, and 200+ petabytes of multimodal data linked to patient outcomes, so we can make development decisions with more precision, much earlier.
This is not theoretical. We’re well-capitalized and have the leadership to build a generational company. We invest in and advance our own clinical-stage programs, using our AI platform to sharpen trial design, patient selection and biomarker strategy. So therapies reach the patients most likely to benefit, sooner.
How We Build
Pathos does not operate like a traditional biotech. There is no middle management. There are no layers of approval. The company is designed, from the ground up, around small teams of 2–4 subject-matter experts who each command hundreds of AI agents to do the work that used to require dozens of people.
Everyone builds. Everyone ships. Every function at Pathos — from clinical execution to asset selection to the foundation model itself — runs on this model. Our product velocity delivers meaningful outcomes in hours instead of weeks. This is not a future aspiration. It is how we operate today.
The people who thrive here are operators: deep experts who can specify what needs to happen, orchestrate AI agents to execute at scale, and make high-judgment calls that compound over time. If you have spent your career building and shipping AI systems at scale, this is the environment where that experience becomes a superpower.
role
About the Role
Pathos is building an AI-native biotech platform that turns real-world data and multimodal models into translational biomarker insights that directly shape drug development decisions—from early target validation through late-stage patient selection. We are redefining how oncology drug development is done: integrated, data-driven, and built from first principles.
As a Senior Computational Biologist, you will sit at the intersection of genomics, translational science, and clinical development. You will own and evolve genomics and biomarker pipelines that support our internal and in-licensed oncology assets, with a particular focus on mechanism-based biomarkers, response predictors, resistance biology, and patient stratification. Your work will span discovery through Phase 1/2 clinical trials, with direct impact on indication selection, dose expansion strategy, and Go/No-Go decisions.
You will generate and test biomarker hypotheses using deep genomic and multi-omic data derived from both external cohorts and Pathos-sponsored clinical trials, translating complex molecular signals into actionable insights for clinicians, program teams, and leadership. This role requires not just analytical excellence, but a strong understanding of how biomarkers are operationalized in real drug development settings.
If you want to apply cutting-edge computational and genomics methods to problems that directly determine how cancer drugs are developed and deployed, this is the place to do the most meaningful work of your career.
Key Responsibilities
Design, build, and maintain end-to-end translational genomics pipelines supporting oncology drug programs, including RNA-seq, DNA (SNV/CNV/structural variants), and multi-omic integration. Generate and prioritize genomically grounded hypotheses tailored to different therapeutic modalities, including: Target dependency and pathway activation for small molecules
Expression, heterogeneity, and spatial context for mAbs, bispecifics, and ADCs
Biomarkers of payload sensitivity, internalization, and resistance for ADC programs Lead biomarker discovery and validation efforts across preclinical, translational, and clinical datasets, with a focus on: Predictive and pharmacodynamic biomarkers MOA and pathway activity signatures Resistance and escape mechanisms Analyze and interpret clinical trial biomarker data (Phase 1/2), linking molecular profiles to response, durability, safety, and survival endpoints. Partner closely with clinical, translational, and regulatory teams to: Define biomarker strategies for trial protocols Support dose escalation/expansion decisions Inform indication prioritization and patient enrichment strategies Translate multimodal model outputs and large-scale genomic analyses into clear, defensible recommendations for development teams and leadership. Contribute to cross-program biomarker standards, best practices, and reproducible analysis frameworks across the Pathos portfolio.
Who you are
Training
PhD (or equivalent industry experience) in computational biology, cancer genomics, bioinformatics, or a related field. 5+ years' experience in a pharma or biotech company supporting oncology drug development in a translational, biomarker, or early clinical (Phase 1/2) setting. Technical & Domain Expertise Deep expertise in cancer genomics and transcriptomics, including hands-on experience with RNA-seq and DNA variant analysis in clinical contexts. Strong understanding of translational biomarkers across the drug development lifecycle, from hypothesis generation to clinical readouts. Experience analyzing biomarker data from interventional clinical trials, including response modeling, survival analysis, and subgroup discovery. Experience generating and validating genomic and multi-omic hypotheses across multiple drug modalities, including small molecules, monoclonal antibodies, bispecifics, and ADCs, with an understanding of how mechanism of action shapes biomarker strategy. Strong intuition for modality-specific biomarker requirements, such as target expression thresholds, pathway addiction, synthetic lethality, immune context, and resistance biology. Demonstrated ability to integrate genomic data with clinical endpoints and operational trial data. Familiarity with large oncology datasets (e.g., Tempus, TCGA, AACR GENIE) and applying them to inform development strategy. Fluency in R (and/or Python) with a strong emphasis on reproducibility and scientific rigor. Mindset & Collaboration Thinks like a drug developer, not just a data scientist—understands what makes a biomarker actionable in a real clinical program. Comfortable owning analyses that influence high-stakes decisions, including trial design and program prioritization. Excels at cross-functional collaboration with clinicians, translational scientists, and engineers. Able to clearly communicate complex genomic and biomarker findings to both technical and non-technical stakeholders. Location
This is a hybrid role, requiring up to 3 days per week onsite, in our NYC Headquarters.
Full job record
| Job ID | d7acb4e2a69100eee2531dee5d6589fa27ef6369 |
| Org ID | 25325165-9d82-45f6-8e64-74c33db17449 |
| Source ID | 2d66e9b5-1b63-475c-a03a-943980720722 |
| Board ID | 2d66e9b5-1b63-475c-a03a-943980720722 |
| Provider | rippling |
| Provider Job Key | 86e9bb79-5de8-4bc5-90ee-7886f8d04c87 |
| Title | Senior Computational Biologist, Oncology |
| Normalized Title | — |
| Status | active |
| Active | yes |
| Location Text | New York City, NY, United States |
| Department | Computational Biology |
| Team | — |
| Employment Type | full_time |
| Workplace Type | on_site |
| Remote Policy | — |
| Country | United States |
| Region | NY |
| City | New York City |
| Salary Raw | USD 170000-210000 YEAR |
| Salary Min | 170,000 |
| Salary Max | 210,000 |
| Salary Currency | USD |
| Salary Period | year |
| Source URL | https://ats.rippling.com/pathos/jobs/86e9bb79-5de8-4bc5-90ee-7886f8d04c87 |
| Apply URL | https://ats.rippling.com/pathos/jobs/86e9bb79-5de8-4bc5-90ee-7886f8d04c87 |
| First Seen At | 2026-05-29 07:13:53Z |
| Last Seen At | 2026-06-06 19:47:28Z |
| Last Checked At | 2026-06-06 19:47:28Z |
| Last Changed At | 2026-06-06 19:47:28Z |
| Inactive At | — |
| Source Posted At | 2026-01-09 19:39:20Z |
| Source Updated At | — |
| Raw Payload Uri | s3://job-postings-prod-raw-590183727216/raw/provider=rippling/board=pathos/date=2026-06-06/2026-06-06T19-47-27-796Z-028dedb1434ee889b96d1d2a4c6bc3c2f873f49fd400f2363c422a3c7900117a.json |
Event Fields
{
"content_hash": "26aac9cc68af5f5bce287720f997962d51928da2f7abcd5821ab5160eea3d212",
"source_hash": "fc7ccd174812c430e9892227f0194a370f85cb0ce326bbfe97ff8ac468598a82",
"last_changed_at": "2026-06-06T19:47:28.755Z",
"active_status": "active"
}Parsed Structured
{
"language": "en-us",
"location": {
"raw": "New York City, NY, United States",
"city": "New York City",
"region": "NY",
"country": "United States",
"is_remote": false,
"confidence": 0.98,
"workplace_type": "on_site"
},
"salary_max": 210000,
"salary_min": 170000,
"inferred_at": "2026-06-06T19:47:28.748Z",
"launch_scope": {
"reason": "english_us_canada",
"included": true,
"language": "en-us",
"location": {
"raw": "New York City, NY, United States",
"city": "New York City",
"region": "NY",
"country": "United States",
"is_remote": false,
"confidence": 0.98,
"workplace_type": "on_site"
},
"countries": [
"United States"
]
},
"remote_policy": null,
"salary_period": "year",
"workplace_type": "on_site",
"salary_currency": "USD"
}Extensions
{}Native Structured
{
"list_job": {
"id": "86e9bb79-5de8-4bc5-90ee-7886f8d04c87",
"url": "https://ats.rippling.com/pathos/jobs/86e9bb79-5de8-4bc5-90ee-7886f8d04c87",
"name": "Senior Computational Biologist, Oncology",
"language": "en-US",
"locations": [
{
"city": "New York City",
"name": "New York City, NY",
"state": "New York",
"country": "United States",
"stateCode": "NY",
"countryCode": "US",
"workplaceType": "ON_SITE"
}
],
"department": {
"name": "Computational Biology"
}
},
"detail_job": {
"url": "https://ats.rippling.com/pathos/jobs/86e9bb79-5de8-4bc5-90ee-7886f8d04c87",
"name": "Senior Computational Biologist, Oncology",
"uuid": "86e9bb79-5de8-4bc5-90ee-7886f8d04c87",
"board": {
"logo": {
"url": "https://prod-images.rippling.com/75cf13a9ba76879beceafbfd6df8b524f5ae71d0.png?Expires=1780861648&Signature=Y8RtMl-MmnGidTjgxEvmNQaoga9GUziA8XXAQeD-jnrE5ESzKGneGdmTh3wq9PmxXs~~BXu0MmatY9KC3nfG9aOyiA0lFvLsr77PpXbxpz~AvEepRGmdKVqPo4yDniWQu12skCA2hCJva0mgSScuuQHyfounmTpelMimkevY-veRb1AM~OyDfUuVOoH4zbmCRoypfoqL7jH8DspCDG--tl40MBiylvBvHs8oiMvP5tBnfcP9QqIF5~WFbJbidab-pc300odNwP~BH3MOsNTeK6TRTRCqhoo~m1XrkHjqDFGNPj-GaBiMo38uYzlZ95zL4dSGdtnMQTra61f8sbZeFQ__&Key-Pair-Id=K2Y26R2ZPP26PH",
"name": "logo file-02.png",
"type": "image/png"
},
"slug": "pathos",
"title": "Pathos",
"banner": {
"url": null,
"name": "",
"type": ""
},
"boardURL": "https://ats.rippling.com/pathos/jobs",
"fontType": null,
"subtitle": "Open Positions",
"boardType": "RIPPLING",
"linkColor": null,
"buttonColor": null,
"legalNotice": null,
"buttonTextColor": null,
"noOpeningsMessage": null,
"groupJobsByLocation": false,
"showBoardLogoOnJobPost": false,
"showCompanyInfoUnderJobPost": false
},
"createdOn": "2026-01-09T11:39:20.851000-08:00",
"department": {
"name": "Computational Biology",
"base_department": "Computational Biology",
"department_tree": [
"Computational Biology"
]
},
"companyName": "Pathos",
"description": {
"role": "<meta><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:14pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;text-align:justify;\"><b><strong style=\"color:rgb(0,0,0);font-size:14pt;white-space:pre-wrap;\">About the Role</strong></b></p><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:12pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;text-align:justify;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Pathos is building an AI-native biotech platform that turns real-world data and multimodal models into translational biomarker insights that directly shape drug development decisions—from early target validation through late-stage patient selection. We are redefining how oncology drug development is done: integrated, data-driven, and built from first principles.</span></p><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:12pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;text-align:justify;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">As a Senior Computational Biologist, you will sit at the intersection of genomics, translational science, and clinical development. You will own and evolve genomics and biomarker pipelines that support our internal and in-licensed oncology assets, with a particular focus on mechanism-based biomarkers, response predictors, resistance biology, and patient stratification. Your work will span discovery through Phase 1/2 clinical trials, with direct impact on indication selection, dose expansion strategy, and Go/No-Go decisions.</span></p><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:12pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;text-align:justify;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">You will generate and test biomarker hypotheses using deep genomic and multi-omic data derived from both external cohorts and Pathos-sponsored clinical trials, translating complex molecular signals into actionable insights for clinicians, program teams, and leadership. This role requires not just analytical excellence, but a strong understanding of how biomarkers are operationalized in real drug development settings.</span></p><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:12pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;text-align:justify;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">If you want to apply cutting-edge computational and genomics methods to problems that directly determine how cancer drugs are developed and deployed, this is the place to do the most meaningful work of your career.</span></p><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:12pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;text-align:justify;\"><b><strong style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Key Responsibilities</strong></b></p><ul data-pattern=\"discCircleSquare\" data-depth=\"1\" style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:11pt;font-weight:400;margin:8px 0px;line-height:1.6;padding:0px 0px 0px 32px;list-style-type:disc;\"><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Design, build, and maintain end-to-end translational genomics pipelines supporting oncology drug programs, including RNA-seq, DNA (SNV/CNV/structural variants), and multi-omic integration.</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Generate and prioritize genomically grounded hypotheses tailored to different therapeutic modalities, including:</span></li></ul><ul data-pattern=\"discCircleSquare\" data-depth=\"1\" style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:11pt;font-weight:400;margin:8px 0px;line-height:1.6;padding:0px 0px 0px 32px;list-style-type:disc;\"><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Target dependency and pathway activation for small molecules</span><br><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Expression, heterogeneity, and spatial context for mAbs, bispecifics, and ADCs</span><br><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Biomarkers of payload sensitivity, internalization, and resistance for ADC programs</span></li></ul><ul data-pattern=\"discCircleSquare\" data-depth=\"1\" style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:11pt;font-weight:400;margin:8px 0px;line-height:1.6;padding:0px 0px 0px 32px;list-style-type:disc;\"><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Lead biomarker discovery and validation efforts across preclinical, translational, and clinical datasets, with a focus on:</span></li><li style=\"font-size:12pt;--listitem-marker-color:#000000;list-style:none;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><ul data-pattern=\"discCircleSquare\" data-depth=\"2\" style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:11pt;font-weight:400;margin-left:0px;margin-right:0px;line-height:1.6;padding:0px 0px 0px 32px;list-style-type:circle;\"><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Predictive and pharmacodynamic biomarkers</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">MOA and pathway activity signatures</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Resistance and escape mechanisms</span></li></ul></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Analyze and interpret clinical trial biomarker data (Phase 1/2), linking molecular profiles to response, durability, safety, and survival endpoints.</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Partner closely with clinical, translational, and regulatory teams to:</span></li><li style=\"font-size:12pt;--listitem-marker-color:#000000;list-style:none;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><ul data-pattern=\"discCircleSquare\" data-depth=\"2\" style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:11pt;font-weight:400;margin-left:0px;margin-right:0px;line-height:1.6;padding:0px 0px 0px 32px;list-style-type:circle;\"><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Define biomarker strategies for trial protocols</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Support dose escalation/expansion decisions</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Inform indication prioritization and patient enrichment strategies</span></li></ul></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Translate multimodal model outputs and large-scale genomic analyses into clear, defensible recommendations for development teams and leadership.</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Contribute to cross-program biomarker standards, best practices, and reproducible analysis frameworks across the Pathos portfolio.</span></li></ul><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:12pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;\"><br></p><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:14pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;\"><b><strong style=\"font-size:14pt;white-space:pre-wrap;\">Who you are</strong></b></p><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:12pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;\"><b><strong style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Training</strong></b></p><ul data-pattern=\"discCircleSquare\" data-depth=\"1\" style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:11pt;font-weight:400;margin:8px 0px;line-height:1.6;padding:0px 0px 0px 32px;list-style-type:disc;\"><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">PhD (or equivalent industry experience) in computational biology, cancer genomics, bioinformatics, or a related field.</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">5+ years' experience in a pharma or biotech company supporting oncology drug development in a translational, biomarker, or early clinical (Phase 1/2) setting.</span></li></ul><h3 style=\"font-family:"Basel Grotesk",Arial,sans-serif;line-height:1.6;font-size:12pt;font-weight:600;letter-spacing:0.25px;margin-top:14px;margin-bottom:4px;text-align:justify;padding-left:0px;\"><b><strong style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Technical & Domain Expertise</strong></b></h3><ul data-pattern=\"discCircleSquare\" data-depth=\"1\" style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:11pt;font-weight:400;margin:8px 0px;line-height:1.6;padding:0px 0px 0px 32px;list-style-type:disc;\"><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Deep expertise in cancer genomics and transcriptomics, including hands-on experience with RNA-seq and DNA variant analysis in clinical contexts.</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Strong understanding of translational biomarkers across the drug development lifecycle, from hypothesis generation to clinical readouts.</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Experience analyzing biomarker data from interventional clinical trials, including response modeling, survival analysis, and subgroup discovery.</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Experience generating and validating genomic and multi-omic hypotheses across multiple drug modalities, including small molecules, monoclonal antibodies, bispecifics, and ADCs, with an understanding of how mechanism of action shapes biomarker strategy.</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Strong intuition for modality-specific biomarker requirements, such as target expression thresholds, pathway addiction, synthetic lethality, immune context, and resistance biology.</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Demonstrated ability to integrate genomic data with clinical endpoints and operational trial data.</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Familiarity with large oncology datasets (e.g., Tempus, TCGA, AACR GENIE) and applying them to inform development strategy.</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Fluency in R (and/or Python) with a strong emphasis on reproducibility and scientific rigor.</span></li></ul><h3 style=\"font-family:"Basel Grotesk",Arial,sans-serif;line-height:1.6;font-size:12pt;font-weight:600;letter-spacing:0.25px;margin-top:14px;margin-bottom:4px;text-align:justify;padding-left:0px;\"><b><strong style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Mindset & Collaboration</strong></b></h3><ul data-pattern=\"discCircleSquare\" data-depth=\"1\" style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:11pt;font-weight:400;margin:8px 0px;line-height:1.6;padding:0px 0px 0px 32px;list-style-type:disc;\"><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Thinks like a drug developer, not just a data scientist—understands what makes a biomarker actionable in a real clinical program.</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Comfortable owning analyses that influence high-stakes decisions, including trial design and program prioritization.</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Excels at cross-functional collaboration with clinicians, translational scientists, and engineers.</span></li><li style=\"color:rgb(0,0,0);font-size:12pt;--listitem-marker-color:#000000;margin:3px 0px;letter-spacing:0.25px;line-height:1.6;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">Able to clearly communicate complex genomic and biomarker findings to both technical and non-technical stakeholders.</span></li></ul><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:14pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;\"><b><strong style=\"color:rgb(0,0,0);font-size:14pt;white-space:pre-wrap;\">Location</strong></b></p><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:12pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;\"><span style=\"color:rgb(0,0,0);font-size:12pt;white-space:pre-wrap;\">This is a hybrid role, requiring up to 3 days per week onsite, in our NYC Headquarters.</span></p><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:12pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;text-align:justify;\"><br></p><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:12pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;\"><br></p>",
"company": "<meta><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:12pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;\"><span style=\"font-size:12pt;white-space:pre-wrap;\">Drug development shouldn’t be guesswork, not when patients are waiting.</span></p><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:12pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;\"><br><span style=\"font-size:12pt;white-space:pre-wrap;\">Pathos is building a next-generation biotech with AI at the core. Not as a feature, but as the operating system for how medicines get developed. We believe most drugs don’t fail because the science was wrong. They fail because they were tested in the wrong patients, with the wrong assumptions, in trials that couldn’t answer the real question: who benefits, and why?</span></p><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:12pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;\"><br><span style=\"font-size:12pt;white-space:pre-wrap;\">Pathos exists to change that. We’re building the largest foundation model in oncology and pairing it with proprietary AI systems, deep oncology expertise, and 200+ petabytes of multimodal data linked to patient outcomes, so we can make development decisions with more precision, much earlier.</span></p><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:12pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;\"><br><span style=\"font-size:12pt;white-space:pre-wrap;\">This is not theoretical. We’re well-capitalized and have the leadership to build a generational company. We invest in and advance our own clinical-stage programs, using our AI platform to sharpen trial design, patient selection and biomarker strategy. So therapies reach the patients most likely to benefit, sooner.</span><br><br><b><strong style=\"font-size:12pt;white-space:pre-wrap;\">How We Build</strong></b><br><span style=\"font-size:12pt;white-space:pre-wrap;\">Pathos does not operate like a traditional biotech. There is no middle management. There are no layers of approval. The company is designed, from the ground up, around small teams of 2–4 subject-matter experts who each command hundreds of AI agents to do the work that used to require dozens of people.</span></p><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:12pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;\"><br><span style=\"font-size:12pt;white-space:pre-wrap;\">Everyone builds. Everyone ships. Every function at Pathos — from clinical execution to asset selection to the foundation model itself — runs on this model. Our product velocity delivers meaningful outcomes in hours instead of weeks. This is not a future aspiration. It is how we operate today.</span></p><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:12pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;\"><br><span style=\"font-size:12pt;white-space:pre-wrap;\">The people who thrive here are operators: deep experts who can specify what needs to happen, orchestrate AI agents to execute at scale, and make high-judgment calls that compound over time. If you have spent your career building and shipping AI systems at scale, this is the environment where that experience becomes a superpower.</span></p><p style=\"font-family:"Basel Grotesk",Arial,sans-serif;font-size:11pt;font-weight:400;line-height:1.6;letter-spacing:0.25px;margin:4px 0px;padding:0px;\"><br></p>"
},
"workLocations": [
"New York City, NY"
],
"employmentType": {
"id": "Salaried, full-time",
"label": "SALARIED_FT"
},
"payRangeDetails": [
{
"currency": "USD",
"isRemote": false,
"location": "New York Office",
"rangeEnd": 210000,
"frequency": "YEAR",
"rangeStart": 170000
}
],
"activeJobApplication": {
"basicQuestions": [
{
"oid": "first_name",
"title": "First name",
"required": true,
"fieldType": "SHORT_ANSWER"
},
{
"oid": "last_name",
"title": "Last name",
"required": true,
"fieldType": "SHORT_ANSWER"
},
{
"oid": "email",
"title": "Email",
"required": true,
"fieldType": "SHORT_ANSWER"
},
{
"oid": "pronouns",
"title": "Pronouns",
"required": false,
"fieldType": "PRONOUN"
},
{
"oid": "current_company",
"title": "Current company",
"required": false,
"fieldType": "SHORT_ANSWER"
},
{
"oid": "phone_number",
"title": "Phone number",
"required": true,
"fieldType": "PHONE_NUMBER"
},
{
"oid": "location",
"title": "Location (city only)",
"required": true,
"fieldType": "SHORT_ANSWER"
},
{
"oid": "resume",
"title": "Resume",
"required": true,
"fieldType": "FILE"
},
{
"oid": "cover_letter",
"title": "Cover letter",
"required": false,
"fieldType": "FILE"
}
],
"customQuestions": {
"fields": [
{
"oid": "first_name",
"title": "First name",
"required": true,
"fieldData": {},
"fieldType": "SHORT_ANSWER"
},
{
"oid": "last_name",
"title": "Last name",
"required": true,
"fieldData": {},
"fieldType": "SHORT_ANSWER"
},
{
"oid": "email",
"title": "Email",
"required": true,
"fieldData": {},
"fieldType": "SHORT_ANSWER"
},
{
"oid": "pronouns",
"title": "Pronouns",
"required": false,
"fieldData": {},
"fieldType": "PRONOUN"
},
{
"oid": "current_company",
"title": "Current company",
"required": false,
"fieldData": {},
"fieldType": "SHORT_ANSWER"
},
{
"oid": "phone_number",
"title": "Phone number",
"required": true,
"fieldData": {},
"fieldType": "PHONE_NUMBER"
},
{
"oid": "location",
"title": "Location (city only)",
"required": true,
"fieldData": {},
"fieldType": "SHORT_ANSWER"
},
{
"oid": "resume",
"title": "Resume",
"required": true,
"fieldData": {},
"fieldType": "FILE"
},
{
"oid": "cover_letter",
"title": "Cover letter",
"required": false,
"fieldData": {},
"fieldType": "FILE"
}
]
},
"additionalQuestions": [
{
"id": "6a0dde20f94237f65612e037",
"form": {
"sections": [],
"questions": [
{
"tags": [],
"title": "Are you authorized to work in the United States for any employer?",
"canEdit": false,
"dataType": "enum",
"isPrivate": false,
"uniqueKey": "f6ea6520-606c-4b98-9f34-d2c7e6070465",
"intChoices": [],
"isRequired": true,
"strChoices": [
"Yes",
"No"
],
"description": "",
"questionType": "SINGLE_SELECT_DROPDOWN",
"allowComments": false,
"isOtherEnabled": false,
"isMultiSelectEnabled": false
},
{
"tags": [],
"title": "Will you now or in the future require visa sponsorship?",
"canEdit": false,
"dataType": "enum",
"isPrivate": false,
"uniqueKey": "7c22ab4c-4058-44fd-b118-4aa69fdf93f0",
"intChoices": [],
"isRequired": true,
"strChoices": [
"Yes",
"No"
],
"questionType": "SINGLE_SELECT_DROPDOWN",
"allowComments": false,
"isOtherEnabled": false,
"isMultiSelectEnabled": false
}
],
"skipLogic": [],
"deletedSections": [],
"deletedQuestions": []
},
"name": "Work Authorization"
},
{
"id": "6a0dde20f94237f65612e038",
"form": {
"sections": [],
"questions": [
{
"tags": [],
"title": "This role is based in our NYC HQ with an onsite requirement of at least 3 days per week. We are unable to offer relocation assistance presently. If you don't currently live in a commutable range, would you relocate without company assistance?",
"canEdit": false,
"dataType": "enum",
"isPrivate": false,
"uniqueKey": "d8e9d4af-cce9-4c16-83cf-32cca6490045",
"intChoices": [],
"isRequired": true,
"strChoices": [
"Yes",
"No"
],
"description": "",
"questionType": "SINGLE_SELECT_DROPDOWN",
"allowComments": true,
"isOtherEnabled": false,
"isMultiSelectEnabled": false
}
],
"skipLogic": [],
"deletedSections": [],
"deletedQuestions": []
},
"name": "NYC Location question 3 days"
}
]
},
"hasAIEvaluationsEnabled": false,
"eeocQuestionnaireEnabled": true,
"applicationConfirmationTemplate": "655be3f8334869f2386920eb",
"eeocQuestionnaireEnabledForJobPost": true
},
"detail_meta": {
"url": "https://ats.rippling.com/api/v2/board/pathos/jobs/86e9bb79-5de8-4bc5-90ee-7886f8d04c87",
"http_status": 200,
"content_type": "application/json",
"response_bytes": 25986
},
"detail_errors": []
}Get this page with API
Rendered from the bluedoor Job Postings API. Reproduce it:
GET https://api.bluedoor.sh/job-postings/v1/jobs/d7acb4e2a69100eee2531dee5d6589fa27ef6369?include=descriptionJSONGET https://api.bluedoor.sh/job-postings/v1/orgs/25325165-9d82-45f6-8e64-74c33db17449JSONGET https://api.bluedoor.sh/job-postings/v1/sources/2d66e9b5-1b63-475c-a03a-943980720722JSONGET https://api.bluedoor.sh/job-postings/v1/jobs/d7acb4e2a69100eee2531dee5d6589fa27ef6369/eventsJSON